Table 2.

Concentrations of serum HA and ALT in each group of rats (mean±SD).

Group	n	HA (ng/mL)	ALT (U/L)
Control	16	192.52±41.97	32.40±2.30
Hepatic fibrosis	12	316.17±78.48a	174.50±6.02b
Non-DSHX-treated	10	300.86±72.73a	104.75±6.54bd
DSHX-treated	10	200.78±31.71ce	93.13±5.79df

^aP<0.05,

^bP<0.01 vs normal control group;

^cP<0.05,

^dP<0.01 vs hepatic fibrosis group;

^eP<0.05,

^fP<0.01 vs non-DSHX-treated group.